Indus Gene Expressions Profile
Key Indicators
- Authorised Capital ₹ 100.00 Cr
- Paid Up Capital ₹ 92.83 Cr
- Company Age 18 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 32.63 Cr
- Satisfied Charges ₹ 30.40 Cr
- Revenue Growth 1429.59%
- Profit Growth -48.25%
- Ebitda -1122.12%
- Net Worth 25.80%
- Total Assets 17.94%
About Indus Gene Expressions
Indus Gene Expressions Limited (IGEL) is a Public Limited Indian Non-Government Company incorporated in India on 09 February 2007 and has a history of 18 years and three months. Its registered office is in Ananthapur, Andhra Pradesh, India.
The Corporate was formerly known as Sri Balaji Biopharmaceuticals India Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 100.00 Cr and a paid-up capital of Rs 92.83 Cr.
The company currently has active open charges totaling ₹32.63 Cr. The company has closed loans amounting to ₹30.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Indus Gene Expressions Limited India are Neha Agarwal as COMPANY SECRETARY and Usharani C as Cfo. Rupana Nallari, Channa C, Usharani C, and Three other members serve as directors at the Company.
Company Details
- Location
Ananthapur, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231AP2007PLC113311
- Company No.
113311
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
09 Feb 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Life Sciences
Indus Gene Expressions Limited
Explore comprehensive data for Indus Gene Expressions Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Indus Gene Expressions?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neha Agarwal | Company Secretary | 11-May-2024 | Current |
Usharani C  | CFO | 03-Apr-2019 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rupana Nallari  | Director | 07-Oct-2013 | Current |
| Channa C | Director | 06-Nov-2008 | Current |
| Usharani C | Director and Cfo | 01-Jan-2009 | Current |
| Himadeep Nallavadla | Director | 27-Apr-2013 | Current |
| Meka Reddy | Additional Director | 06-May-2022 | Current |
| Avula Reddy | Additional Director | 28-Oct-2019 | Current |
Financial Performance of Indus Gene Expressions.
Indus Gene Expressions Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1429.59% increase. The company also saw a substantial fall in profitability, with a 48.25% decrease in profit. The company's net worth Soared by an impressive increase of 25.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indus Gene Expressions?
In 2022, Indus Gene Expressions had a promoter holding of 44.22% and a public holding of 55.78%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Xemx Projects Private LimitedHimadeep Nallavadla is a mutual person
Pennzymes International Private LimitedChanna C is a mutual person
- Dr.Reddy Solar Energy And Systems Private Limited
Channa C and Usharani C are mutual person
- Vaikha Llp
Himadeep Nallavadla is a mutual person
- Vishnuka Power Private Limited
Himadeep Nallavadla is a mutual person
- Poorva Solar Power Private Limited
Himadeep Nallavadla is a mutual person
Charges (Loans)
Open Charges
₹32.63 Cr
Satisfied Charges
₹30.40 Cr
Charges Breakdown by Lending Institutions
- Syndicate Bank : 29.00 Cr
- Canara Bank : 3.63 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Sep 2020 | Canara Bank | ₹3.63 Cr | Open |
| 21 Dec 2019 | Syndicate Bank | ₹29.00 Cr | Open |
| 13 Oct 2014 | Andhra Bank | ₹30.40 Cr | Satisfied |
How Many Employees Work at Indus Gene Expressions?
Unlock and access historical data on people associated with Indus Gene Expressions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indus Gene Expressions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indus Gene Expressions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Indus Gene Expressions
Recent activity within the organization
- Director Appointment
Neha Agarwal was appointed as a Company Secretary was appointed as a Company Secretary on 11 May 2024 & has been associated with this company since 1 year 1 day .
- Annual General Meeting
Indus Gene Expressions Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Indus Gene Expressions Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Vijayawada.
- Director Appointment
Meka Sudhakara Reddy was appointed as a Additional Director was appointed as a Additional Director on 06 May 2022 & has been associated with this company since 3 years 7 days .
- Charges
A charge with Canara Bank amounted to Rs. 3.63 Cr with Charge ID 100369900 was registered on 04 Sep 2020.
- Charges
A charge with Syndicate Bank amounted to Rs. 29.00 Cr with Charge ID 100313774 was registered on 21 Dec 2019.
Frequently asked questions
What is the Incorporation or founding date of Indus Gene Expressions Limited?
Indus Gene Expressions Limited was incorporated on 09 Feb 2007.
What is authorized share capital and paid-up capital of Indus Gene Expressions Limited?
The authorized share capital of Indus Gene Expressions Limited is ₹ 100.00 Cr and paid-up capital is ₹ 92.83 Cr.
Who are the current board members & directors of Indus Gene Expressions Limited?
Currently 8 directors are associated with Indus Gene Expressions Limited.
- Rupana Reddy Nallari
- Channa Reddy C
- Usharani Reddy C
- Himadeep Nallavadla
- Meka Sudhakara Reddy
- Avula Sreenivasa Reddy
- Neha Agarwal
- Usharani Reddy C
What is the registered address of Indus Gene Expressions Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Indus Gene Expressions Limited is 6-312 Kodur Village, Kanisettipalli Post India, Chilamathur Mandal, Andhra Pradesh, 515341.
What is the corporate identification number (CIN) and company number of Indus Gene Expressions Limited?
The corporate identification number (CIN) of Indus Gene Expressions Limited is U24231AP2007PLC113311 and the company number is 113311 as per Ministry of Corporate Affairs (MCA).
What is the official website of Indus Gene Expressions Limited?
The Official website of Indus Gene Expressions Limited is https://www.indusgenetech.com
What has been the recent revenue trend for Indus Gene Expressions Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Indus Gene Expressions Limited has risen by 1429.59%.
What change has been observed in the net worth of Indus Gene Expressions Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Indus Gene Expressions Limited has experienced an upsurge of 25.80%.
What are the total open charges for Indus Gene Expressions Limited?
As per the financial statements for fiscal Year 2022, The total open charges for Indus Gene Expressions Limited amount to ₹ 32.63 Cr.
When was the last Balance Sheet of Indus Gene Expressions Limited filed with the ROC?
The most recent Balance Sheet for Indus Gene Expressions Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
PK
Prasada KambhamDirectorVY
Veerabhadrareddy YerramDirectorYV
Yerram VikranthreddyDirectorVR
Venkata ReddyDirectorHP
Harshavardhan PedakalaDirectorRN
Rupana NallariDirectorHN
Himadeep NallavadlaDirectorGN
Gonuguntla NirmalaDirector
Similar Companies Based on Biotechnology
Venkateshwara B.V. Biocorp Private Limited Pune, Maharashtra, India
Sanofi Healthcare India Private Limited Mumbai, Maharashtra, India
Biotechnology Industry Research Assistance Council Delhi, India
Invitrogen Bioservices India Private Limited Bangaluru, Karnataka, India
Ecso Global Private Limited New Delhi, India
Gennova Biopharmaceuticals Limited Pune, Maharashtra, India
Aurigene Oncology Limited Bangaluru, Karnataka, India